Caffeine induces g0/g1 cell cycle arrest and inhibits migration through Integrin αv, β3, and FAK/AKT/c-MYC signaling pathway

by Pichitchai Meisaprow, Nithikoon Aksorn, Chanida Vinayanuwattikun, Pithi Chanvorachote, Monruedee Sukprasansap
Published 2022

Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells

by Hardyanti Eka Putri, Bodee Nutho, Thanyada Rungrotmongkol, Boonchoo Sritularak, Chanida Vinayanuwattikun, Pithi Chanvorachote
Published 2022

Titania nanosheet generates peroxynitrite-dependent S-nitrosylation and enhances p53 function in lung cancer cells

by Rapeepun Soonnarong, Sucharat Tungsukruthai, Bodee Nutho, Thanyada Rungrotmongkol, Chanida Vinayanuwattikun, Tosapol Maluangnont, Pithi Chanvorachote
Published 2022

Novel c-Myc-Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells

by Nicharat Sriratanasak, Korrakod Petsri, Apirat Laobuthee, Worawat Wattanathana, Chanida Vinayanuwattikun, Sudjit Luanpitpong, Pithi Chanvorachote
Published 2020

A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma

by Sudjit Luanpitpong, Napachai Rodboon, Parinya Samart, Chanida Vinayanuwattikun, Siwaporn Klamkhlai, Pithi Chanvorachote, Yon Rojanasakul, Surapol Issaragrisil
Published 2020

GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy

by Zin Zin Ei, Kanuengnit Choochuay, Alisa Tubsuwan, Decha Pinkaew, Maneewan Suksomtip, Chanida Vinayanuwattikun, Pithi Chanvorachote, Preedakorn Chunhacha
Published 2022

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

by Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun
Published 2022

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer

by Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Krittiya Korphaisarn, Nophol Leelayuwatanakul, Nopporn Pornpatrananrak, Naravat Poungvarin, Poonchavist Chantranuwat, Shanop Shuangshoti, Chatchawit Aporntewan, Wariya Chintanapakdee, Virote Sriuranpong, Chanida Vinayanuwattikun
Published 2022